171 results on '"Hollander, S.A."'
Search Results
2. Pediatric Coronary Angiography in the Teammate Trial: Angiographic Core Interpretation over the First 3 Years Post Transplant
3. Immunosuppressant Drug Level Monitoring in Pediatric Heart Transplant Recipients: A Report from the TEAMMATE Trial
4. Memory B Cell Deficiency and Disseminated Nocardiosis in a Pediatric Patient with Congenital Single Ventricle Physiology and Heart Transplantation
5. Long-Term Outcomes of ECMO Post-Heart Transplant
6. Monotherapy Immunosuppression in Pediatric Heart Transplant Recipients
7. A Single Center Look at Pediatric Heart Re-Transplantation
8. Orthotopic Heart Transplant in Toddler with Histiocytoid Cardiomyopathy and Left Ventricular Non-Compaction
9. International Practice Heterogeneity in Pediatric Left Heart Disease Related Pulmonary Hypertension
10. Reducing Donor Acceptance Practice Variation- Learnings from a Discussion Forum
11. Sudden Cardiac Arrest After Pediatric Heart Transplantation
12. Bereaved Caregiver Perspectives on Implantation and End of Life in Pediatric Ventricular Assist Device Patients
13. Oral Aversion and Its Risks in Pediatric Heart Transplant Recipients
14. (1353) - Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency
15. (1348) - Pediatric Coronary Angiography in the Teammate Trial: Angiographic Core Interpretation over the First 3 Years Post Transplant
16. (1258) - Successful Transplantation of Long-Distance Hearts Using Ex-Vivo Preservation System in the Pediatric Population: An Early Case Series
17. (220) - Adverse Events Occur Frequently in the Teammate Trial Cohort: Comparison by Treatment Group During 30 Months of Follow Up
18. (113) - The TEAMMATE Trial: Post-Transplant Outcomes and Social Determinants of Health
19. The Teammate Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial
20. Conversion from Liquid Prograf to Prograf Granules—Lessons Learned from Our Early Experience
21. Transplant Flight Plan and Huddle: Simple Intervention to Improve Communication in Pediatric Heart Transplantation
22. Waitlist Mortality for Children Listed for Heart Transplant in the United States: How are We Doing?
23. UNOS Match Runs for Pediatric Heart Transplant Organ Allocation—How Well Do They Sequence Patients Based on Medical Urgency?
24. Neurologic Events Following Pediatric Heart Transplantation
25. Outcomes of Ventricular Assist Device Use in Children for Bridge to Heart Retransplantation
26. Compassionate Deactivation of Pediatric Ventricular Assist Device Support: Lessons Learned from Our First 14 Cases
27. Heart Transplantation in Children with Trisomy 21
28. Taking a Closer Look at Distance: Does Increasing the Maximal Donor Distance Range Shorten Waitlist Times in Pediatric Heart Transplant Candidates?
29. Impact of High- vs. Low-Frequency Surveillance Endomyocardial Biopsy Strategy in Pediatric Heart Transplantation
30. Waitlist Mortality in US Children Listed for Heart Transplant - Where are We Now?
31. Taking a Closer Look at Distance: Does Increasing the Maximal Donor Distance Range Shorten Waitlist Times in Pediatric Heart Transplant Candidates?
32. Conversion from Compounded Liquid Prograf to Prograf Granules - Lessons Learned from Our Early Experience
33. Clinician Perspectives on the Potential Utility of a Patient Reported Outcomes Measure for Pediatric Heart Failure
34. Palliative Care Involvement in Pediatric VAD Patients - A Single Center Experience
35. Novel Trans-Septal Left Atrial VAD Cannulation Technique for Hypertrophic/Restrictive Cardiomyopathy
36. Failure to Improve Renal Function Following VAD Placement Predicts Renal Injury and Chronic Kidney Disease Following Cardiac Transplant
37. Nutritional Rehabilitation of Pediatric Patients on Ventricular Assist Device Support
38. Center Variation in Listing Parameters Among US Pediatric Heart Transplant Programs
39. Cardiac Predictors of Renal Recovery After Pediatric Left Ventricular Assist Device (LVAD) Implantation
40. Compassionate Deactivation of Ventricular Assist Devices in Children: A Survey of Pediatric VAD Clinicians’ Perspectives and Practices
41. Avoidance of a C1q Positive Crossmatch Prevents Both Early and Late Antibody-Mediated Rejection in Pediatric Heart Transplant Recipients
42. Outcomes of US Patients with Marfans Syndrome Listed for Heart Transplantation
43. Are Implantable Cardioverter-Defibrillators Indicated in Pediatric Ventricular Assist Device Patients?
44. Hemodynamic Findings Associated with End-Organ Dysfunction in Children with End-Stage Heart Failure
45. Poverty Is an Independent Socioeconomic Risk Factor for Death Following Pediatric Heart Transplant
46. Utility of the Routine Screening Echocardiogram After Endomyocardial Biopsy for Identification of Hemopericardium or Tricuspid Valve Injury
47. The End-of-Life Experience in Pediatric Heart Transplant Recipients
48. Rehospitalization Following Pediatric Heart Transplant: Frequency, Indications, and Outcomes
49. Development and Validation of a Major Adverse Transplant Event (MATE) Score to Predict Graft Loss after Pediatric Heart Transplantation
50. (1018) - Center Variation in Listing Parameters Among US Pediatric Heart Transplant Programs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.